Glutathione
ProtocolProtocol design for Glutathione starts with pharmacokinetics and ends with calendar planning. The compound's Minutes IV; longer cellular pool half-life via subq/iv/nebulised/oral (poor absorption, prefer liposomal) administration places it in the multi-daily-dosing bucket; cycle length is 8-12 weeks with a 4-week off-period; stack integration follows route compatibility and receptor non-overlap principles.
Key Takeaways
Scheduling lens: Glutathione's Minutes IV; longer cellular pool half-life via subq/iv/nebulised/oral (poor absorption, prefer liposomal) places it in the multi-daily-dosing bucket. Mechanism: Reduced form (GSH) donates electrons to neutralise reactive oxygen species and supports glutathione peroxidase, glutathione-S-transferase, and Phase II conjugation pathways. Cycle structure: 8-12 weeks on, 4 weeks off; the off-period is functionally required for receptor reset. Stack scheduling: add one compound at a time with 2 weeks of isolated dosing before layering. Schedule-compatible stack partners: BPC-157, TB-500, Ipamorelin.
Reduced form (GSH) donates electrons to neutralise reactive oxygen species and supports glutathione peroxidase, glutathione-S-transferase, and Phase II conjugation pathways. Critical cofactor in liver detoxification. Recycled by glutathione reductase using NADPH. Schedule design for Glutathione starts from the pharmacokinetic constraints implied by this mechanism and the published half-life. The subsections below address daily and weekly timing, cycle length and off-period planning, stack scheduling with other compounds, and travel-and-continuity considerations.
Cycle length and off-cycle planning
Standard Glutathione cycle length is 8–12 weeks for most users, with off-cycle periods of 4–6 weeks calibrated to allow receptor sensitivity to recover and any cumulative downregulation to resolve. The off-cycle is not optional in well-designed protocols; it is the period during which the dose response is reset for the next cycle.
Stack scheduling with other compounds
When Glutathione is part of a multi-compound stack, the scheduling question becomes how to time its dose relative to the others. Multiple subcutaneous compounds can be combined in a single injection where compatible, or staggered through the day where pharmacokinetics differ meaningfully. The pragmatic schedule reflects both pharmacokinetic constraints and the user's operational reality.
Travel, schedule shifts, and continuity
Maintaining cycle continuity through travel, time-zone shifts, and irregular schedules is one of the practical considerations for any Glutathione protocol. Cold-chain requirements (where applicable), customs considerations for international travel, and adjustment for time-zone shifts within a 24–48 hour window are the main operational issues. For most Glutathione schedules a ±8-hour timing shift has no clinical effect; longer shifts warrant minor schedule adjustment.
For stack scheduling scheduling, Glutathione is best run in 8–12 week cycles with 4 week off-periods. Daily timing within the cycle is calibrated to pharmacokinetics; weekly timing is calibrated to training and lifestyle constraints. The schedule is the protocol.
The most-asked scheduling question for Glutathione in pulse strategies is when to time doses relative to meals and training. The general principle: fasted dosing for compounds engaging the GH axis or AMPK; meal-paired dosing for incretins; flexibility for compounds whose pharmacokinetics permit it.
Schedule design for Glutathione in off-time starts from pharmacokinetic constraints: less frequent dosing for long half-life compounds. The cycle length and off-period are then layered on top of the daily schedule.
For maintenance phase scheduling, Glutathione is best run in 8–12 week cycles with 4 week off-periods. Daily timing within the cycle is calibrated to pharmacokinetics; weekly timing is calibrated to training and lifestyle constraints. The schedule is the protocol.
| Goal | Route | Dose | Cycle |
|---|---|---|---|
| Standard protocol | SubQ | 200-600 mg | 8–12 weeks on / 4 weeks off |
| Conservative starter | SubQ | 120-600 mg | 4–6 weeks initial cycle |
| Protocol focus | SubQ | 200-600 mg | 2-3x weekly SubQ/IV; daily nebulised |
| Maintenance phase | SubQ | 140-600 mg | Ongoing with periodic pauses |
Dose timing for Glutathione is less time-sensitive given the longer half-life. Consistency through the cycle is more important than the precise clock time of individual doses.
Glutathione stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from protocol designers.
- Glutathione + BPC-157: Upregulates VEGFR2 to promote angiogenesis and activates the FAK-paxillin pathway for accelerated tissue repair. Pairs naturally with Glutathione's mechanism in protocol / scheduling / cycling protocols.
- Glutathione + TB-500: Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool. Pairs naturally with Glutathione's mechanism in protocol / scheduling / cycling protocols.
- Glutathione + Ipamorelin: Highly selective GHSR1a agonist. Pairs naturally with Glutathione's mechanism in protocol / scheduling / cycling protocols.
- Glutathione + CJC-1295 without DAC (Mod GRF 1-29): Same GHRH-receptor agonism as DAC variant. Pairs naturally with Glutathione's mechanism in protocol / scheduling / cycling protocols.
Excellent. Mild sulfur-like smell at injection. Avoid in sulfite sensitivity.
Lens-specific safety considerations for protocol / scheduling / cycling use of Glutathione: Excellent. Mild sulfur-like smell at injection. Avoid in sulfite sensitivity. Additional protocol / scheduling / cycling monitoring at baseline and 6–8 week follow-up is appropriate.
| Compound | Profile | Onset | Best For |
|---|---|---|---|
| Glutathione | Endogenous tripeptide antioxidant | Minutes IV; longer cellular pool | Protocol |
| BPC-157 | Stable gastric pentadecapeptide | ~4 hr (oral) | Accelerated tendon, ligament, and gut tissue repair via VEGFR2-driven angiogenesis and FAK-paxillin signalling |
| TB-500 | Synthetic thymosin β4 fragment | ~2-3 days | A 17-amino-acid synthetic fragment of thymosin β4 with actin-sequestering activity — drives cell migration, tissue repair, and broad regenerative effects |
| Ipamorelin | Selective GHRP / ghrelin mimetic | ~2 hr | The most selective ghrelin-receptor agonist among the GHRPs — stimulates GH release with minimal effect on cortisol, prolactin, or appetite |
| GHK-Cu | Tripeptide-copper complex | ~30 min plasma | A naturally occurring tripeptide-copper complex that declines with age and is studied for its broad effects on wound healing, skin remodelling, and gene expression |
Daily timing for Glutathione?
Can I shift my schedule with travel?
When to integrate Glutathione into an existing stack?
What if I miss a dose?
What is Glutathione?
What should I look for in Glutathione sourcing and quality?
Start a Glutathione Protocol
Alukard provides physician-supervised peptide protocols with GMP-certified Glutathione and GMP-certified compounds with personalised cycle design.
Get ProtocolQuick Facts
- Molecular weight
- 307 Da
- Sequence length
- 3 aa
- Half-life
- Minutes IV; longer cellular pool
- WADA
- Not on prohibited list
- FDA
- Approved by various routes; injection unapproved formulation
- Research
- Extensive
Stack Partners
All protocol / scheduling / cycling applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for Glutathione unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.
Start Your Protocol / Scheduling / Cycling Protocol for Glutathione
Alukard provides physician-supervised peptide protocols with GMP-certified compounds with personalised cycle design.
HIPAA Compliant · GMP Certified · Physician Supervised